Work

Supplementary Table S4 from Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling

Year: 2024

Type: supplementary-materials

Abstract: Supplementary Table S4: Overall and cancer-specific relative reductions in late-stage incidence for MCED trials with varying numbers of annual screens and with specified overall mean sojourn time (OMST) and late-stage mean sojourn time (LMST) assumptions, assuming early- and late-stage test sensitivities for each cancer are 100% of those reported in clinically diagnosed patients.

DOI: 10.1158/1055-9965.25956977

Authors: Jane M. Lange, Kemal Caglar Gogebakan, Roman Gulati, Ruth Etzioni

Language: English

Topic: Global Cancer Incidence and Screening

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4399292635

Cites:

Cited by:

Related to: 10